BML-259
Modify Date: 2025-09-18 19:20:45
BML-259 structure
|
Common Name | BML-259 | ||
|---|---|---|---|---|
| CAS Number | 267654-00-2 | Molecular Weight | 260.35 | |
| Density | 1.2±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C14H16N2OS | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of BML-259BML-259 is a potent cyclin-dependent kinase 5 (Cdk5) inhibitor, with IC50s of 64 and 98 nM for Cdk5 and Cdk2, respectively[1]. |
| Name | 2-phenyl-N-(5-propan-2-yl-1,3-thiazol-2-yl)acetamide |
|---|---|
| Synonym | More Synonyms |
| Description | BML-259 is a potent cyclin-dependent kinase 5 (Cdk5) inhibitor, with IC50s of 64 and 98 nM for Cdk5 and Cdk2, respectively[1]. |
|---|---|
| Related Catalog | |
| In Vitro | BML-259 (10 μM) protects large population of cells against non-Aβ component of Alzheimer's disease amyloid (NAC)-evoked cell death[2]. |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Molecular Formula | C14H16N2OS |
| Molecular Weight | 260.35 |
| Exact Mass | 260.098328 |
| PSA | 70.23000 |
| LogP | 3.88 |
| Index of Refraction | 1.618 |
| InChIKey | IGRZXNLKVUEFDM-UHFFFAOYSA-N |
| SMILES | CC(C)c1cnc(NC(=O)Cc2ccccc2)s1 |
| 2-phenyl-N-[5-(propan-2-yl)-1,3-thiazol-2-yl]acetamide |
| Benzeneacetamide, N-[5-(1-methylethyl)-2-thiazolyl]- |
| N-(5-Isopropyl-1,3-thiazol-2-yl)-2-phenylacetamide |